Stockscreener 앱 받기
0.9883
1.17%
-0.0117
시장 영업 전:
1.00
0.0117
+1.18%
전일 마감가:
$1.00
열려 있는:
$1
하루 거래량:
55,225
Relative Volume:
0.22
시가총액:
$60.22M
수익:
$33.79M
순이익/손실:
$-18.67M
주가수익비율:
-2.7591
EPS:
-0.3582
순현금흐름:
$-19.17M
1주 성능:
-1.17%
1개월 성능:
+5.52%
6개월 성능:
-17.64%
1년 성능:
-3.11%
1일 변동 폭
$0.9699
$1.02
1주일 범위
$0.9699
$1.02
52주 변동 폭
$0.70
$1.59
Cytosorbents Corp Stock (CTSO) Company Profile
명칭
Cytosorbents Corp
전화
973-329-8885
주소
305 COLLEGE ROAD EAST, PRINCETON, NJ
CTSO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.9883 | 60.22M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
129.10 | 223.92B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.54 | 152.60B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.39 | 149.59B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.97 | 116.65B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.33 | 42.07B | 6.60B | 4.16B | 490.10M | 6.93 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-07 | 개시 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2020-09-17 | 개시 | Jefferies | Buy |
| 2020-09-01 | 개시 | SVB Leerink | Outperform |
| 2017-08-08 | 재확인 | Maxim Group | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-05-24 | 개시 | Maxim Group | Buy |
| 2015-10-29 | 업그레이드 | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 재확인 | MLV & Co | Buy |
| 2015-04-01 | 재확인 | MLV & Co | Buy |
| 2015-03-05 | 개시 | MLV & Co | Buy |
| 2015-02-25 | 개시 | WBB Securities | Speculative Buy |
| 2015-01-27 | 재확인 | H.C. Wainwright | Buy |
모두보기
Cytosorbents Corp 주식(CTSO)의 최신 뉴스
Cytosorbents Co. (NASDAQ:CTSO) Sees Significant Increase in Short Interest - MarketBeat
Cytosorbents (NASDAQ:CTSO) Stock Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Vanguard Group Inc's Strategic Acquisition of CytoSorbents Corp Shares - GuruFocus.com
Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World
Chief Medical Officer Deliargyris Efthymios exercised 16,233 in-the-money shares at a strike of $1.00, increasing direct ownership by 4% to 403,025 units (SEC Form 4) - Quantisnow
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - MarketBeat
CytoSorbents Strengthens Balance Sheet with Successful Conclusion of Rights Offering - Defense World
Cytosorbents Boosts Liquidity with Successful Rights Offering - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral Capital - Defense World
CytoSorbents closes oversubscribed rights offering - MSN
D. Boral Capital Reiterates Buy Rating for Cytosorbents (NASDAQ:CTSO) - MarketBeat
Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts - Benzinga
CytoSorbents Raises $6.25M in Oversubscribed Rights Offering, Unlocks $5M Restricted Cash - StockTitan
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - Defense World
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Cytosorbents Co. (NASDAQ:CTSO) Stake Boosted by Geode Capital Management LLC - Defense World
Skylands Capital, LLC Increases Stake in CytoSorbents Corp - GuruFocus.com
Revenue Surge & Breakthrough Margins Fuel Growth in Critical Care Tech - Streetwise Reports
CytoSorbents opens new sales subsidiary in Dubai - Investing.com
CytoSorbents Expands Global Reach with Strategic Dubai Hub for Middle East & Africa Growth - StockTitan
CytoSorbents reported strong Q4 results, says D. Boral Capital - Yahoo Finance
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth - Benzinga
Cytosorbents' (CTSO) Buy Rating Reiterated at D. Boral Capital - MarketBeat
CytoSorbents reports revenue growth in Q4 - Investing.com
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue - Quantisnow
CytoSorbents Delivers Strong Q4 Growth: Product Revenue Surges 25%, Margins Hit 70% Milestone - StockTitan
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - MarketBeat
Comparing Cytosorbents (NASDAQ:CTSO) & Presbia (OTCMKTS:LENSF) - Defense World
CytoSorbents begins rights offering for stockholders - Investing.com
CytoSorbents Launches $1.00 Rights Offering with Discounted Warrant Package for Shareholders - StockTitan
CytoSorbents Rights Offering Begins - GlobeNewswire
StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
Peter J. Mariani Purchases 20,000 Shares of Cytosorbents Co. (NASDAQ:CTSO) Stock - MarketBeat
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock - Investing.com India
Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock By Investing.com - Investing.com Nigeria
Cytosorbents Co. (NASDAQ:CTSO) Short Interest Update - MarketBeat
Cytosorbents CFO Peter Mariani buys $27,974 in stock - Investing.com
KORU Medical Systems (NASDAQ:KRMD) and Cytosorbents (NASDAQ:CTSO) Head-To-Head Comparison - Defense World
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week - Yahoo Finance
CytoSorbents Announces Commencement of Shareholder Rights Warrant Offering - Defense World
CTSOCytosorbents Corp. Latest Stock News & Market Updates - StockTitan
CytoSorbents sets terms for anticipated Rights Offering - Investing.com
SEC Form FWP filed by Cytosorbents Corporation - Quantisnow
CytoSorbents Announces Rights Offering - Quantisnow
CTSO (CytoSorbents) 3-Year Revenue Growth Rate : -11.80% (As of Sep. 2024) - GuruFocus.com
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference - StockTitan
Cytosorbents Corp (CTSO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.33%
0.49%
자본화:
|
볼륨(24시간):